US Patent Issued to IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY on April 29 for "Organoselenium benzimidazole compounds for treating cancer" (Saudi Arabia, Egyptian, Iraqi Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,412, issued on April 29, was assigned to IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (Riyadh, Saudi Arabia).

"Organoselenium benzimidazole compounds for treating cancer" was invented by Tarek Ahmed Yousef (Riyadh, Saudi Arabia), Saad Shaaban (Almansourah, Egypt) and Ahmed A. Al-Karmalawy (Baghdad).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating cancer that includes administering a therapeutically effective amount of an organoselenium benzimidazole compound of Formula (I),where R is at least one selected from the group consisting of an alkyl group having 1 to 6 carbon atoms, an unsubstituted benzyl group, a para halo-substituted benzy...